Your browser doesn't support javascript.
loading
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors.
Louveau, Baptiste; Delyon, Julie; De Moura, Coralie Reger; Battistella, Maxime; Jouenne, Fanelie; Golmard, Lisa; Sadoux, Aurelie; Podgorniak, Marie-Pierre; Chami, Ichrak; Marco, Oren; Caramel, Julie; Dalle, Stephane; Feugeas, Jean-Paul; Dumaz, Nicolas; Lebbe, Celeste; Mourah, Samia.
Afiliación
  • Louveau B; Paris-Diderot University, Sorbonne Paris Cité, Paris, France.
  • Delyon J; Paris-Diderot University, Inserm, UMR_S976, Paris, France.
  • De Moura CR; Department of Pharmacogenomics, Saint-Louis Hospital, AP-HP, Paris, France.
  • Battistella M; Paris-Diderot University, Sorbonne Paris Cité, Paris, France.
  • Jouenne F; Paris-Diderot University, Inserm, UMR_S976, Paris, France.
  • Golmard L; Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Sadoux A; Paris-Diderot University, Inserm, UMR_S976, Paris, France.
  • Podgorniak MP; Department of Pharmacogenomics, Saint-Louis Hospital, AP-HP, Paris, France.
  • Chami I; Paris-Diderot University, Sorbonne Paris Cité, Paris, France.
  • Marco O; Department of Pathology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Caramel J; Paris Diderot University, Inserm, UMR_S1165, Paris, France.
  • Dalle S; Paris-Diderot University, Sorbonne Paris Cité, Paris, France.
  • Feugeas JP; Paris-Diderot University, Inserm, UMR_S976, Paris, France.
  • Dumaz N; Department of Pharmacogenomics, Saint-Louis Hospital, AP-HP, Paris, France.
  • Lebbe C; Department of Genetics, Pôle de Médecine Diagnostique et Théranostique, Institut Curie, Paris, France.
  • Mourah S; Paris-Diderot University, Sorbonne Paris Cité, Paris, France.
Oncotarget ; 10(18): 1669-1687, 2019 Mar 01.
Article en En | MEDLINE | ID: mdl-30899440

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: Francia